Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$5.62 USD
-0.16 (-2.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $5.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Inovio Pharmaceuticals (INO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.75 | $33.00 | $8.00 | 172.49% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Inovio Pharmaceuticals comes to $15.75. The forecasts range from a low of $8.00 to a high of $33.00. The average price target represents an increase of 172.49% from the last closing price of $5.78.
Analyst Price Targets (6 )
Broker Rating
Inovio Pharmaceuticals currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, three are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Hold | Hold |
7/15/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Hold | Hold |
5/14/2024 | Stephens | Sudan Loganathan | Not Available | Strong Buy |
1/4/2024 | JMP Securities | Roy Buchanan | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 6 |
Average Target Price | $15.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -1.20 |
INO FAQs
Inovio Pharmaceuticals, Inc. (INO) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Inovio Pharmaceuticals, Inc. (INO) is $15.75. The current on short-term price targets is based on 4 reports.
The forecasts for Inovio Pharmaceuticals, Inc. (INO) range from a low of $8 to a high of $33. The average price target represents a increase of $180.25 from the last closing price of $5.62.
The current UPSIDE for Inovio Pharmaceuticals, Inc. (INO) is 180.25%
Based on short-term price targets offered by six analysts, the average price target for Inovio Pharmaceuticals comes to $15.75. The forecasts range from a low of $8.00 to a high of $33.00. The average price target represents an increase of 172.49% from the last closing price of $5.78.